← FDA Drug Approvals (Drugs@FDA)

DARZALEX

BLA · Biologics License Application · Sponsor: JANSSEN BIOTECH · Approved 2015-11-16

Drug application

FDA Application #
BLA761036
Application type
Biologics License Application
Brand name
DARZALEX
Generic name
DARATUMUMAB
Active ingredients
DARATUMUMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
JANSSEN BIOTECH
Manufacturer
Janssen Biotech, Inc.
First approval
2015-11-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown